Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | tyrosyl-DNA phosphodiesterase | 0.0075 | 0.0738 | 0.0421 |
Schistosoma mansoni | hypothetical protein | 0.0347 | 0.6618 | 1 |
Entamoeba histolytica | glycogenphosphorylase, putative | 0.0098 | 0.123 | 0.3071 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0056 | 0.0331 | 0.0501 |
Brugia malayi | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0065 | 0.0526 | 0.0526 |
Echinococcus granulosus | tyrosyl DNA phosphodiesterase 1 | 0.0075 | 0.0738 | 0.0995 |
Echinococcus granulosus | Glycosyl transferase family 35 | 0.0226 | 0.4006 | 0.5399 |
Schistosoma mansoni | glycogen phosphorylase | 0.0098 | 0.123 | 0.1859 |
Leishmania major | tyrosyl-DNA phosphodiesterase 1 | 0.0075 | 0.0738 | 1 |
Brugia malayi | Tyrosyl-DNA phosphodiesterase family protein | 0.0075 | 0.0738 | 0.0738 |
Schistosoma mansoni | tyrosyl-DNA phosphodiesterase | 0.0075 | 0.0738 | 0.1115 |
Giardia lamblia | Glycogen phosphorylase | 0.0226 | 0.4006 | 0.5 |
Echinococcus granulosus | glycogen phosphorylase | 0.0226 | 0.4006 | 0.5399 |
Echinococcus granulosus | transcription factor Dp 1 | 0.0043 | 0.0055 | 0.0074 |
Onchocerca volvulus | Glycogen phosphorylase homolog | 0.0226 | 0.4006 | 0.38 |
Trichomonas vaginalis | glycogen phosphorylase, putative | 0.0226 | 0.4006 | 0.5 |
Loa Loa (eye worm) | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0061 | 0.0431 | 0.0103 |
Echinococcus multilocularis | glycogen phosphorylase | 0.0226 | 0.4006 | 0.5399 |
Echinococcus multilocularis | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0065 | 0.0526 | 0.0708 |
Echinococcus granulosus | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0065 | 0.0526 | 0.0708 |
Chlamydia trachomatis | glycogen phosphorylase | 0.0226 | 0.4006 | 0.5 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.0226 | 0.4006 | 1 |
Schistosoma mansoni | lozenge | 0.0063 | 0.0481 | 0.0727 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.0098 | 0.123 | 0.3071 |
Schistosoma mansoni | glycogen phosphorylase | 0.0226 | 0.4006 | 0.6053 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.0226 | 0.4006 | 1 |
Echinococcus multilocularis | Protein lozenge | 0.0063 | 0.0481 | 0.0649 |
Mycobacterium tuberculosis | Probable glycogen phosphorylase GlgP | 0.0098 | 0.123 | 1 |
Schistosoma mansoni | 3-hydroxyacyl-CoA dehydrogenase | 0.0065 | 0.0526 | 0.0794 |
Echinococcus multilocularis | tyrosyl DNA phosphodiesterase 1 | 0.0075 | 0.0738 | 0.0995 |
Echinococcus multilocularis | Glycosyl transferase, family 35 | 0.0226 | 0.4006 | 0.5399 |
Entamoeba histolytica | tyrosyl-DNA phosphodiesterase, putative | 0.0075 | 0.0738 | 0.1843 |
Echinococcus granulosus | tumor protein p63 | 0.0384 | 0.7419 | 1 |
Loa Loa (eye worm) | runx1 | 0.0063 | 0.0481 | 0.0155 |
Echinococcus multilocularis | tumor protein p63 | 0.0384 | 0.7419 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0503 | 1 | 1 |
Loa Loa (eye worm) | glycogen phosphorylase | 0.0226 | 0.4006 | 0.38 |
Echinococcus granulosus | glycogen phosphorylase | 0.0226 | 0.4006 | 0.5399 |
Trypanosoma brucei | RNA helicase, putative | 0.0347 | 0.6618 | 1 |
Brugia malayi | carbohydrate phosphorylase | 0.0226 | 0.4006 | 0.4006 |
Loa Loa (eye worm) | hypothetical protein | 0.0503 | 1 | 1 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0075 | 0.0738 | 0.5 |
Echinococcus multilocularis | glycogen phosphorylase | 0.0226 | 0.4006 | 0.5399 |
Onchocerca volvulus | 0.0503 | 1 | 1 | |
Schistosoma mansoni | glycogen phosphorylase | 0.0226 | 0.4006 | 0.6053 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.0098 | 0.123 | 0.3071 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0075 | 0.0738 | 0.5 |
Trichomonas vaginalis | glycogen phosphorylase, putative | 0.0226 | 0.4006 | 0.5 |
Echinococcus multilocularis | transcription factor Dp 1 | 0.0043 | 0.0055 | 0.0074 |
Mycobacterium ulcerans | glycogen phosphorylase GlgP | 0.0098 | 0.123 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Immobility (functional) | = 13 % | Evaluated for catalepsy activity in mice and percentage immobility was determined at a concentration of 0 mg/Kg. | ChEMBL. | 2158563 |
Immobility (functional) | = 13 % | Evaluated for catalepsy activity in mice and percentage immobility was determined at a concentration of 0 mg/Kg. | ChEMBL. | 2158563 |
Immobility (functional) | = 15 % | Evaluated for catalepsy activity in mice and percentage immobility was determined at a concentration of 5 mg/kg. | ChEMBL. | 2158563 |
Immobility (functional) | = 15 % | Evaluated for catalepsy activity in mice and percentage immobility was determined at a concentration of 5 mg/kg. | ChEMBL. | 2158563 |
Immobility (functional) | = 24 % | Evaluated for catalepsy activity in mice and percentage immobility was determined at a concentration of 3 mg/Kg. | ChEMBL. | 2158563 |
Immobility (functional) | = 24 % | Evaluated for catalepsy activity in mice and percentage immobility was determined at a concentration of 3 mg/Kg. | ChEMBL. | 2158563 |
Spont activity (functional) | < 25 Counts 10min-1 | Evaluated for reduction in spontaneous locomotor activity in mice at a dose of 6 mg/Kg | ChEMBL. | 2158563 |
Spont activity (functional) | < 25 Counts 10min-1 | Evaluated for reduction in spontaneous locomotor activity in mice at a dose of 6 mg/Kg | ChEMBL. | 2158563 |
Spont activity (functional) | < 42 Counts 10min-1 | Evaluated for reduction in spontaneous locomotor activity in mice at a dose of 5 mg/Kg | ChEMBL. | 2158563 |
Spont activity (functional) | < 42 Counts 10min-1 | Evaluated for reduction in spontaneous locomotor activity in mice at a dose of 5 mg/Kg | ChEMBL. | 2158563 |
Spont activity (functional) | < 43 Counts 10min-1 | Evaluated for reduction in spontaneous locomotor activity in mice at a dose of 3 mg/Kg | ChEMBL. | 2158563 |
Spont activity (functional) | < 43 Counts 10min-1 | Evaluated for reduction in spontaneous locomotor activity in mice at a dose of 3 mg/Kg | ChEMBL. | 2158563 |
Spont activity (functional) | = 68 Counts 10min-1 | Evaluated for reduction in spontaneous locomotor activity in mice, at a dose of 0 mg/Kg | ChEMBL. | 2158563 |
Spont activity (functional) | = 68 Counts 10min-1 | Evaluated for reduction in spontaneous locomotor activity in mice, at a dose of 0 mg/Kg | ChEMBL. | 2158563 |
Tail flick latency (functional) | = 0.6 s | Tail-flick latency was determined at a concentration of 0 mg/Kg. | ChEMBL. | 2158563 |
Tail flick latency (functional) | = 0.6 s | Tail-flick latency was determined at a concentration of 0 mg/Kg. | ChEMBL. | 2158563 |
Tail flick latency (functional) | = 1.1 s | Tail-flick latency was determined at a concentration of 3 mg/Kg. | ChEMBL. | 2158563 |
Tail flick latency (functional) | = 1.1 s | Tail-flick latency was determined at a concentration of 6 mg/kg. | ChEMBL. | 2158563 |
Tail flick latency (functional) | = 1.1 s | Tail-flick latency was determined at a concentration of 3 mg/Kg. | ChEMBL. | 2158563 |
Tail flick latency (functional) | = 1.1 s | Tail-flick latency was determined at a concentration of 6 mg/kg. | ChEMBL. | 2158563 |
Tail flick latency (functional) | < 1.9 s | Tail-flick latency was determined at a concentration of 5 mg/Kg. | ChEMBL. | 2158563 |
Tail flick latency (functional) | < 1.9 s | Tail-flick latency was determined at a concentration of 5 mg/Kg. | ChEMBL. | 2158563 |
Temperature (functional) | < -3 degrees C | Evaluated for hypothermic activity in mice at a dose of 6 mg/kg. | ChEMBL. | 2158563 |
Temperature (functional) | < -3 degrees C | Evaluated for hypothermic activity in mice at a dose of 6 mg/kg. | ChEMBL. | 2158563 |
Temperature (functional) | = -1.1 degrees C | Evaluated for hypothermic activity in mice at a dose of 3 mg/kg. | ChEMBL. | 2158563 |
Temperature (functional) | = -1.1 degrees C | Evaluated for hypothermic activity in mice at a dose of 3 mg/kg. | ChEMBL. | 2158563 |
Temperature (functional) | = -0.8 degrees C | Evaluated for hypothermic activity in mice at a dose of 0 mg/Kg. | ChEMBL. | 2158563 |
Temperature (functional) | = -0.8 degrees C | Evaluated for hypothermic activity in mice at a dose of 0 mg/Kg. | ChEMBL. | 2158563 |
Temperature (functional) | = -0.7 degrees C | Evaluated for hypothermic activity in mice at a dose of 5 mg/Kg. | ChEMBL. | 2158563 |
Temperature (functional) | = -0.7 degrees C | Evaluated for hypothermic activity in mice at a dose of 5 mg/Kg. | ChEMBL. | 2158563 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.